CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

What makes your blood different from someone else’s is your unique combination of protein molecules, called antigens and antibodies. Antigens live on the surface of your red blood cells.

VUMC received up to $30M to develop AI for antibody therapy discovery, aiming to create an antibody-antigen atlas and ...

Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

The trispecific antibody market is rapidly advancing, with 50+ candidates in clinical trials and first approvals expected by 2028. These next-gen immunotherapies target three distinct antigens, ...

Vanderbilt University Medical Center has been awarded up to $30 million by the Advanced Research Projects Agency for Health ...

An ambitious project led by Vanderbilt University Medical Center investigators aims to use artificial intelligence ...

Antigenic variation is a key mechanism by which pathogens evade the immune system. New research has shown how trypanosomes change their antigen expression.

The immune system responds to an infection by producing antibodies that recognize and bind to the cell surface of the pathogen, thus marking it as an intruder and triggering an immune response. For ...

A new study by LMU and Helmholtz Munich shows how the pathogen Trypanosoma brucei controls changes in its cell surface to evade the immune ...

Oxford Biotherapeutics Ltd. is partnering with Roche AG to expand the current field of tumor antigens that can be drugged with antibodies, as part of a potential $1 billion-plus agreement. The ...

The global polyclonal antibody market is poised for significant expansion in the coming decade, driven by increasing ...